Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Authors

Showing 5 results for author "Naveen Pemmaraju".

Back to authors

Thumbnail for Characterization of Edema Adverse Events in the CADENZA Study of Pivekimab Sunirine (PVEK) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

AML - 1153

Characterization of Edema Adverse Events in the CADENZA Study of Pivekimab Sunirine (PVEK) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Naveen Pemmaraju

Poster Presenter: Naveen Pemmaraju

Thumbnail for The Efficacy of Pivekimab Sunirine (PVEK) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm With Baseline Skin Involvement in the CADENZA Study

AML - 477

The Efficacy of Pivekimab Sunirine (PVEK) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm With Baseline Skin Involvement in the CADENZA Study

Naveen Pemmaraju

Poster Presenter: Naveen Pemmaraju

Thumbnail for Benefit of Rusfertide Maintained in Patients With Low-Risk or High-Risk Polycythemia Vera: Efficacy and Safety Subgroup Analysis From the Randomized Controlled Phase 3 VERIFY Study

MPN - 161

Benefit of Rusfertide Maintained in Patients With Low-Risk or High-Risk Polycythemia Vera: Efficacy and Safety Subgroup Analysis From the Randomized Controlled Phase 3 VERIFY Study

Naveen Pemmaraju

Poster Presenter: Naveen Pemmaraju

Thumbnail for Healthcare Provider Perspectives on the Therapeutic Phlebotomy Workflow in Polycythemia Vera and Associated Resource Use in the United States

MPN - 558

Healthcare Provider Perspectives on the Therapeutic Phlebotomy Workflow in Polycythemia Vera and Associated Resource Use in the United States

Naveen Pemmaraju

Poster Presenter: Naveen Pemmaraju

Thumbnail for Real-World Treatment Patterns and Outcomes in Patients With Myelofibrosis Treated With First-Line Pacritinib or Ruxolitinib

MPN - 564

Real-World Treatment Patterns and Outcomes in Patients With Myelofibrosis Treated With First-Line Pacritinib or Ruxolitinib

Naveen Pemmaraju

Poster Presenter: Naveen Pemmaraju

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.